News

  
Boston-based Immunetics, Inc. awarded $1.2 million for new test development
Boston-based Immunetics, Inc. awarded $2.5 million for clinical trials
CDC collaboration yields new anthrax test
Peptide ELISA eliminates vaccine cross-reactivity
Return to News & Events
News
FDA Approves Apheresis Platelet Claims for Immunetics' BacTx Rapid Test for Bacterial Contamination
Read more...
View Full Article
Leading Physicians to Discuss “Advances in Bacterial Testing of Platelets: BacTx Field Experience” at American Association of Blood Banks (AABB) Annual Meeting
Read more...
View Full Article
Immunetics Receives $3.7 Million NIH Contract for Babesia Blood Screening Test
Read more...
View Full Article
Immunetics Receives FDA Clearance for BacTx Rapid Test for Bacterial Contamination of Platelets
Read more...
View Full Article
AIM International Business Council (AIM-IBC) Announces 2012 Global Trade Award Winners
Read more...
View Full Article
Immunetics, Inc. to Present Novel, Rapid Test for Bacterial Contamination of Platelets at American Association of Blood Banks (AABB) Annual Meeting
Read more...
View Full Article
MassDevelopment Loans Allow Immunetics to Manufacture & Launch BacTx Test for Bacterial Contamination in Blood Platelet Transfusions
Read more...
View Full Article
Immunetics Receives $500,000 from Massachusetts Life Sciences Center to Commercialize BacTx® Test for Bacterial Contamination in Blood Platelet Transfusions
Read more...
View Full Article
Immunetics Awarded $2.4 Million NIH Grant for Clinical Trials of New Blood Test for Chagas’ Disease
Read more...
View Full Article
Immunetics Featured at Boston Startup America Event
Read more...
View Full Article
National Institutes of Health awards two grants for infectious disease tests
Read more...
View Full Article
National Institutes of Health awards $2.5 million  grant for new bacterial test
Read more...
QuickELISA™ Anthrax-PA Kit first to win FDA approval for clinical diagnosis
Read more...
View Full Article
Events
TBD